Kazakhstan vs Romania: The number of people with susceptibility test result for rifampicin
Kazakhstan
5,121
in 2021
Romania
4,366
in 2021
Kazakhstan rank
28th
Romania rank
31st
The number of people with susceptibility test result for rifampicin over time
- Kazakhstan
- Romania
How they compare
Kazakhstan currently reports 5,121 against 4,366 in Romania, a difference of 755.
That makes Kazakhstan's figure about 1.2 times Romania's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Romania ahead.
Kazakhstan ranks 28th and Romania ranks 31st of 155 countries.
Across the 2 decades both report, Kazakhstan averaged higher in 1 and Romania in 1.
Head to head by decade
| Decade | Kazakhstan | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5,272 | 6,018 | 746 | Romania |
| 2020s | 4,990 | 3,988 | 1,002 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kazakhstan or Romania?
- Kazakhstan, at 5,121 against 4,366 in Romania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kazakhstan and Romania?
- 755, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Romania?
- 5 years are reported by both, from 2017 to 2021.
- How do Kazakhstan and Romania rank globally for the number of people with susceptibility test result for rifampicin?
- Kazakhstan ranks 28th and Romania ranks 31st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.